Journal Papers, Abstracts, and Commentaries
| |
Age-Specific Global Prevalence of Hepatitis B,
Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic
Review.
Kinner SA, Snow K, Wirtz AL, et al
J Adolesc Health. 2018
Mar;62(3S):S18-S26.
Abstract
Prevention of Hepatitis C by Screening and
Treatment in U.S. Prisons.
He T, Li K, Roberts MS, et al
Ann Intern Med. 2015 Nov 24.
Abstract
creening for Hepatitis C as a Prevention
Enhancement (SHAPE) for HIV: An Integration Pilot Initiative in a Massachusetts
County
Correctional Facility.
Cocoros N, Nettle E, Church D, et al
Public Health Rep. 2014
Jan;129 Suppl 1:5-11.
Abstract
A simple strategy to identify acute HCV infection
among newly incarcerated injection drug users.
Kim AY, Nagami EH, Birch CE,
et al
Hepatology. 2012 Oct 30.
Abstract
FULL-TEXT
ARTICLE
Prison puzzle: Treating hepatitis C.
Webster PC.
CMAJ.
2012 May 7.
Paper
FULL-TEXT LETTER
Tuberculosis Screening before Anti-Hepatitis C Virus
Therapy in Prisons.
Babudieri S, Soddu A, Murino M,
et al
Emerg Infect Dis. 2012 Apr;18(4):689-91
Commentary
FULL-TEXT ARTICLE
Screening for HCV Infection in Jails
Spaulding,
AC Thomas, DL
JAMA. 2012 Mar 28; 307(12): 1259–1260
Paper
|
|
|
Videos
| |
|
Hepatitis C in Corrections |
|
Journal Papers, Abstracts, and Commentaries
| |
|
FULL-TEXT
ARTICLE
Genotype distribution and treatment response among
incarcerated drug-dependent patients with chronic hepatitis C infection.
Cheng CH, Lin CC, Chen HL, et al
PLoS
One. 2018 Feb
1;13(2):e0191799.
Paper
FULL-TEXT ARTICLE
Why is there still hepatitis C transmission in Australian
prisons? A case report.
Harkness B, Levy M, Evans R, Wenke J.
Harm Reduct J. 2017 Nov 25;14
Paper
Hepatitis C antibody prevalence among Mexico City
prisoners injecting legal and illegal substances.
Silverman-Retana O, Serván-Mori E, McCoy SI, Larney
S, Bautista-Arredondo S.
Drug Alcohol Depend.
2017 Oct 14
Abstract
HIV and HCV in U.S. Prisons and Jails: The
Correctional Facility as a Bellwether Over Time for the Community's Infections.
Spaulding AC, Anderson EJ,
AIDS Rev. 2017 Sep
19;19(3). [
Abstract
FULL-TEXT ARTICLE
Use of multiple data sources to estimate hepatitis C
seroprevalence among prisoners: A retrospective cohort study.
Snow KJ, Richards AH, Kinner SA.
PLoS One. 2017 Jul
7;12(7):e0180646.
Paper
FULL-TEXT ARTICLE
Risk factors for prevalent hepatitis C virus-infection
among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF, Mosqueda-Gomez JL, et al.
PLoS One. 2017 Jun
27;12(6):e0179931
Paper
FULL-TEXT ARTICLE
Risk factors for prevalent hepatitis C virus-infection
among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF, Mosqueda-Gomez JL, et al
PLoS One. 2017 Jun 27;12(6):e0179931.
Paper
Modelling the impact of incarceration and prison-based
hepatitis C virus (HCV) treatment on HCV transmission among people who inject
drugs in Scotland.
Stone J, Martin NK, Hickman M, et al
Addiction. 2017 Mar 3.
Abstract
Ongoing incident hepatitis C virus infection among people with a
history of injecting drug use in an Australian prison setting, 2005-2014:
the HITS-p study.
Cunningham EB, Harjarizadeh B, Bretana NA, et al
J Vral Hepat. 2017 Mar
Abstract
FULL-TEXT ARTICLE
Prevalence and Incidence of HCV Infection among Prisoners
in Central Brazil.
Puga MA, Bandeira LM, Pompilio
MA, et al
PLoS One. 2017 Jan
6;12(1):e0169195.
Paper
Correlates of Hepatitis C Virus Infection in the Targeted Testing
Program of the New York City Jail System.
Akiyama MJ, Kaba F, Rosner Z,
et al
Public Health Rep. 2017
Jan/Feb;132(1):41-47.
Abstract
Social capital strategies to enhance hepatitis C
treatment awareness and uptake among men in prison.
Lafferty L, Treloar C, Guthrie J,
et al
J Viral Hepat. 2016 Oct 24.
Abstract
Hepatitis C management in prisons: An insight
into daily clinical practice in three major Italian correctional houses.
Foschi A, Casana M, Radice A,
et al
Hepatology. 2016
Nov;64(5):1821-1822.
Abstract
A systematic review and meta-analysis of racial and ethnic
disparities in hepatitis C antibody prevalence in United States correctional
populations.
Larney S, Zaller ND, Dumont DM,
et al
Ann Epidemiol. 2016 Jul 14.
Abstract
Correlates and characteristics of hepatitis C
virus-specific T-cell immunity in exposed uninfected high-risk prison inmates.
Cameron B, Galbraith S,
Li H, et al
J Viral Hepat. 2013 Apr;20(4):e96-e106.
Abstract
The incidence and prevalence of hepatitis C in
prisons and other closed settings: Results of a systematic review and
meta-analysis.
Larney S,
Kopinski H, Beckwith CG,
et al
Hepatology.
2013 Mar 15.
Abstract
Low incidence of HCV amongst
prisoners in Scotland.
Taylor A, Munro A, Allen
E, et al
Addiction. 2013 Jan 8
Abstract |
Re-infection of hepatitis C virus
infection in HIV/HCV co-infected inmates of correctional
institutions, Canada.
Farley J, Truong A, Horvath G, et al
J Int AIDS Soc.
2012 Nov 11;15(6):18422.
Abstract
FULL-TEXT
ARTICLE
Prevalence of anti-HCV in an inmate population.
Rosa FD, Carneiro M, Duro LN,
et al
Rev Assoc Med Bras.
2012 Oct;58(5):557-560
Paper
FULL-TEXT ARTICLE
Hepatitis C Virus and Associated Risk Factors among
Prison Inmates with History of Drug Injection in Isfahan, Iran.
Kassaian N, Adibi P, Kafashaian A, et al
Int J Prev Med.
2012 Mar;3(Suppl1):S156-S16
Paper
Estimating the variability in the risk of
infection for hepatitis C in the Glasgow injecting drug user population.
Sutton AJ, McDonald SA, Palmateer N,
et al
Epidemiol Infect. 2012 Mar 30:1-0
>
Comparison of hepatitis C virus treatment
between incarcerated and community patients.
Rice JP, Burnett D, Tsotsis
H,
et al
Hepatology.
2012 Apr 13.
Abstract
'Prevalence
of HCV risk behaviors among prison inmates: tattooing and injection drug
use.
Peña-Orellana M,
Hernández-Viver A,
et al
J Health Care Poor Underserved.
2011;22(3):962-82.
Abstract
Hepatitis C and B prevalence in Spanish
prisons.
Saiz de la Hoya P,
Marco A, García-Guerrero J, Rivera A
Eur J Clin Microbiol Infect Dis.
2011 Jan 28.
Abstract
A "One-Two Punch" Leading to Hepatitis C
Seroconversion.
Nagami EH, Kim AY, Birch CE,
et al
Clin Infect Dis. 2010 Dec 28.
Abstract |
Frequent multiple hepatitis C virus infections
among injection drug users in a prison setting.
Pham ST, Bull RA, Bennett JM,
et al
Hepatology. 2010 Nov;52(5):1564-72
Abstract |
FULL-TEXT PDF ARTICLE
Incidence of primary hepatitis C infection and risk
factors for transmission in an Australian prisoner cohort.
Teutsch S, Luciani F, Scheuer N, et al
BMC Public Health.
2010 Oct 22;10(1):633
Paper |
High prevalence of late relapse and reinfection in
prisoners treated for chronic hepatitis C.
Bate JP, Colman AJ, Frost PJ, Shaw DR, Harley HA.
J Gastroenterol Hepatol.
2010 Jul;25(7):1276-1280
Abstract |
Chronic hepatitis C in the state prison system: insights
into the problems and possible solutions.
Imperial JC.
Expert Rev Gastroenterol Hepatol.
2010 Jun;4(3):355-64
Abstract
|
Establishment of a successful assessment and treatment
service for Australian prison inmates with chronic hepatitis C.
Boonwaat L, Haber PS, Levy MH, Lloyd AR.
Med J Aust.
2010 May 3;192(9):496-500.
Abstract |
Incidence and risk for acute hepatitis C
infection during imprisonment in Australia.
Dolan K, Teutsch S, Scheuer N, et al
Eur J Epidemiol. 2010 Jan 19.
Abstract |
|
|
|
|
|
|
Journal Papers, Abstracts, and Commentaries
Journal
Papers, Abstracts, and Commentaries
| |
FULL-TEXT ARTICLE
Genotype distribution and treatment response among
incarcerated drug-dependent patients with chronic hepatitis C infection.
Cheng CH, Lin CC, Chen HL, et al
PLoS One. 2018 Feb 1;13(2):e0191799.
Paper
Management of HCV infection in the penitentiary setting
in the direct-acting antivirals era: practical recommendations from an
expert panel.
Roberto R, Giulio S, Sergio C, et al
Infection.
2016 Dec 26
Abstract
FULL-TEXT ARTICLE
Hepatitis C virus infection and prisoners:
Epidemiology, outcome and treatment.
Zampino R, Coppola N, Sagnelli C,
et al
World J Hepatol. 2015 Sep
28;7(21):2323-30.
Paper
Multicenter study on the discontinuation
and efficacy of chronic hepatitis C treatment in the Spanish
penitentiary population (EPIBAND study).
Juan JD, de la Hoya PS, Marco A, et al
Eur J Gastroenterol Hepatol.
2014 Jul 29.
Abstract
The progression of liver fibrosis in prison
inmates co-infected by HIV and HCV who started on boosted protease
inhibitor therapy.
Saiz de la Hoya Zamácola P, Alía Alía C, et al
Rev Esp Sanid Penit.
2013 Oct;15(2):54-62.
Abstract
FULL TEXT PDF ARTICLE
Impact of new therapeutics for hepatitis C virus
infection in incarcerated populations.
Spaulding AS, Kim AY, Harzke AJ,
Top Antivir Med.
2013 Feb-Mar;21(1):27-35
Paper
High prevalence of late relapse and
reinfection in prisoners treated for chronic hepatitis C.
Bate JP, Colman AJ, Frost PJ,
et al
J Gastroenterol Hepatol.
2010 Jul;25(7):1276-1280
Abstract |
New opportunities for the management and
therapy of hepatitis C in correctional settings.
Martin CK, Hostetter JE, Hagan JJ.
Am J Public Health. 2010
Jan;100(1):13-7.
Abstract |
|
|
|
|
|
Journal Papers, Abstracts, and Commentaries
|
|
General
Reports 
Prison
Health
Disease Index